MISTY LEE: Open Payments
NPI 1730946385 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,687 in 115 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $151 · 2025 $1,687
Food & beverage: $1,687
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 28 | $280 |
| ABBVIE INC. | 26 | $260 |
| Otsuka America Pharmaceutical, Inc. | 13 | $224 |
| Supernus Pharmaceuticals, Inc. | 10 | $140 |
| Alkermes, Inc. | 5 | $124 |
| Corium, LLC | 7 | $120 |
| Janssen Pharmaceuticals, Inc | 6 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $76 |
| E.R. Squibb & Sons, L.L.C. | 4 | $76 |
| Axsome Therapeutics, Inc. | 2 | $54 |
Products named: CAPLYTA, VRAYLAR, REXULTI, Qelbree, Azstarys, SPRAVATO, ABILIFY MAINTENA, FANAPT.
Industry payments across KY — which companies pay providers there.
